Characteristics of Coronary Lesions in Small Vessel Disease Treated with Elective Stenting in Patients with Type 2 Diabetes Mellitus

1. Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature. 2001;414:782-787.10.1038/414782aSearch in Google Scholar

2. Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care. 1993;16:434-444.10.2337/diacare.16.2.434Search in Google Scholar

3. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998;339:229-234.10.1056/NEJM199807233390404Search in Google Scholar

4. Kornowski R, Mintz GS, Kent KM, et al. Increased restenosis in diabetes mellitus after coronary interventions is due to exaggerated intimal hyperplasia. A serial intravascular ultrasound study. Circulation. 1997;95(6):1366-1369.10.1161/01.CIR.95.6.1366Search in Google Scholar

5. Mintz GS. Diabetic Coronary Artery Disease. JACC. 2008;52(4):263-265.10.1016/j.jacc.2008.04.020Search in Google Scholar

6. Scognamiglio R, Negut C, Ramondo A, Tiengo A, Avogaro A. Detection of Coronary Artery Disease in Asymptomatic Patients With Type 2 Diabetes Mellitus. J Am Coll Cardiol. 2006;47(1):65-71.10.1016/j.jacc.2005.10.008Search in Google Scholar

7. Srinivasan MP, Kamath KP, Bhat NM, et al. Severity of coronary artery disease in type 2 diabetes mellitus: Does the timing matter? Indian Heart J. 2016;68(2):158-163.10.1016/j.ihj.2015.08.004Search in Google Scholar

8. Aronson D, Edelman ER. Revascularization for coronary artery disease in diabetes mellitus: Angioplasty, stents and coronary artery bypass grafting. Rev Endocr Metab Disord. 2010;11(1):75-86.10.1007/s11154-010-9135-3Search in Google Scholar

9. Wiebe J, Nef HM, Hamm CW. Current Status of Bioresorbable Scaffolds in the Treatment of Coronary Artery Disease. J Am Coll Cardiol. 2014;64(23):2541-2551.10.1016/j.jacc.2014.09.041Search in Google Scholar

10. Pletcher MJ, Tice JA, Pignone M, McCulloch C, Callister TQ, Browner WS. What does my patient's coronary artery calcium score mean? Combining information from the coronary artery calcium score with information from conventional risk factors to estimate coronary heart disease risk. BMC Med. 2004;2:31.10.1186/1741-7015-2-31Search in Google Scholar

11. Moses JW1, Leon MB, Popma JJ et al. Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary Artery. N Engl J Med. 2003;349(14):1315-23.10.1056/NEJMoa035071Search in Google Scholar

12. Wiebe J, Nef HM, Hamm CW. Current status of bioresorbable scaffolds in the treatment of coronary artery disease. J Am Coll Cardiol. 2014 Dec 16;64(23):2541-2551.10.1016/j.jacc.2014.09.041Search in Google Scholar

13. Joner M, Finn AV, Farb A, et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol. 2006;48:193–202.10.1016/j.jacc.2006.03.042Search in Google Scholar

14. Onuma Y1, Serruys PW. Bioresorbable scaffold: the advent of a new era in percutaneous coronary and peripheral revascularization? Circulation. 2011 Feb 22;123(7):779-97.10.1161/CIRCULATIONAHA.110.971606Search in Google Scholar

15. Nikolsky E, Mehran R, Dangas G, et al. Development and validation of a prognostic risk score for major bleeding in patients undergoing percutaneous coronary intervention via the femoral approach. Eur Heart J. 2007 Aug;28(16):1936-1945.10.1093/eurheartj/ehm194Search in Google Scholar

16. Spuentrup E, Ruebben A, Mahnken A, et al. Artifact-free coronary magnetic resonance angiography and coronary vessel wall imaging in the presence of a new, metallic, coronary magnetic resonance imaging stent. Circulation. 2005;111:1019-1026.10.1161/01.CIR.0000156462.97532.8FSearch in Google Scholar

17. Verheye S, Ormiston JA, Stewart J, et al. A next-generation bioresorbable coronary scaffold system-from bench to first clinical evaluation: 6- and 12-month clinical and multimodality imaging results. J Am Coll Cardiol Intv. 2014;7:89-99.10.1016/j.jcin.2013.07.007Search in Google Scholar

18. Dörr O, Liebetrau C, Wiebe J, et al. Bioresorbable scaffolds for the treatment of in-stent restenosis. Heart Vessels. 2015;30(2):265-269.10.1007/s00380-013-0464-5Search in Google Scholar

19. Greenland P, Bonow RO, Brundage BH, et al. ACCF/AHA 2007 Clinical Expert Consensus Document on Coronary Artery Calcium Scoring By Computed Tomography in Global Cardiovascular Risk Assessment and in Evaluation of Patients With Chest Pain. J Am Coll Cardiol. 2007;49(3):378-402.10.1016/j.jacc.2006.10.001Search in Google Scholar

20. Raggi P, Shaw LJ, Berman DS, Callister TQ. Prognostic value of coronary artery calcium screening in subjects with and without diabetes. J Am Coll Cardiol. 2004;43:1663-1669.10.1016/j.jacc.2003.09.068Search in Google Scholar

21. Grundy SM, Benjamin IJ, Burke GL, et al. Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation. 1999;100:1134-1146.10.1161/01.CIR.100.10.1134Search in Google Scholar

22. Arad Y, Newstein D, Cadet F, Roth M, Guerci AD. Association of multiple risk factors and insulin resistance with increased prevalence of asymptomatic coronary artery disease by an electron-beam computed tomographic study. Arterioscler Thromb Vasc Biol. 2001;21(12):2051-2058.10.1161/hq1201.100257Search in Google Scholar